APOP - Cellect Biotechnology News Story
$2.74 0.0 0.4%
Last Trade - 15/01/21
| Market Cap | £4.60m |
| Enterprise Value | £84.6k |
| Revenue | £n/a |
| Position in Universe | 6086th / 6547 |
BRIEF-Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002
Thu 21st May, 2020 9:51pm
May 21 (Reuters) - Cellect Biotechnology Ltd APOP.O :
* CELLECT BIOTECHNOLOGY REPORTS FIRST QUARTER 2020 FINANCIAL
AND
OPERATING RESULTS; CONTINUES TO DEMONSTRATE SIGNIFICANT PROGRESS
DESPITE ADJUSTED OPERATIONS DUE TO COVID-19
* Q1 LOSS PER SHARE $0.002
Source text for Eikon: ID:nPn1hv16Ba
Further company coverage: APOP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellect Biotechnology
See all news
